NavaDerm Partners sells Dermatology and Surgery Associates to Schweiger Dermatology

NavaDerm Partners, LLC, a leading dermatology management platform based in New York City, has sold its Dermatology and Surgery Associates (DSA) practice to Schweiger Dermatology Group. This strategic move highlights NavaDerm’s focus on strengthening its flagship practices while supporting the continued growth of Schweiger Dermatology Group, a dominant player in the Northeast region.

NavaDerm was formed in 2018 through the collaboration of five dermatology groups in New York and New Jersey. The company operates eight locations, delivering exceptional care through over 40 board-certified dermatologists specialising in medical, surgical, and cosmetic dermatology. By consolidating its resources, NavaDerm aims to enhance its flagship services, including its renowned Laser & Skin Surgery of New York and Spring Street Dermatology practices.

Schweiger Dermatology Group, a powerhouse in the U.S. dermatology market, operates more than 120 offices with over 400 healthcare providers. In 2024 alone, the group recorded over two million patient visits, offering a comprehensive range of medical, cosmetic, and surgical dermatology services. The acquisition of DSA expands Schweiger’s presence in the Bronx and positions the group to further capitalise on growing demand in the dermatology sector.

NavaDerm’s Chief Financial Officer stated that this sale marks the third practice the company has sold to Schweiger Dermatology Group in the past year. NavaDerm’s remaining practices in Manhattan and Southampton continue to benefit from robust growth in the cosmetic dermatology market, driven by increased consumer interest in aesthetic treatments.

A representative from Schweiger Dermatology Group expressed excitement about the acquisition, underscoring its significance in expanding the group’s reach across the Northeast. The acquisition aligns with Schweiger’s long-term strategy of consolidating regional practices to build a leading dermatology network.

BelHealth Investment Partners, LLC, NavaDerm’s parent company, is a private equity firm focused on healthcare investments in lower-middle-market companies. Based in Fort Lauderdale, Florida, BelHealth manages a $350 million fund and leverages its expertise in private equity and operations to scale healthcare businesses.

This transaction also reflects a broader trend in the dermatology industry, where private equity firms and major healthcare groups are increasingly acquiring regional practices to consolidate the market. Experts note that such consolidation enables companies to streamline operations, enhance patient care, and capture greater market share.

The financial advisory role for this deal was handled by Brown Gibbons Lang & Company, while Moomjian, Waite & Coleman, LLP served as legal counsel for NavaDerm.

This sale not only strengthens Schweiger Dermatology Group’s foothold in the Northeast but also exemplifies how private equity-backed platforms like NavaDerm are reshaping the dermatology landscape through strategic partnerships and acquisitions.